Enteral tube feeding (ETF) is often used in an attempt to optimize the nutritional status. The aim of this study was to observe the long term effect of ETF and to compare the start of ETF with the current European guidelines on nutrition care in CF.
From all patients who received ETF (ETFp) between February 2000 and September 2016 in the Ghent University Hospital (GUH) or Brussels University Hospital (BUH), z-scores for body weight (W), height (H), growth velocity (GV) and BMI, FEV1%, and FVC% were retrospectively collected from the patients’ medical record, 3 years before and 5 years after the year of ETF initiation. Gender, age, and pancreatic status matched controls were selected from the GUH database.
All baseline (T0) measurements in ETFp were worse compared to controls. Only 11% of the controls had a Hz < −1.6 compared 58% of the ETFp. After the initiation of ETF a rapid weight gain was noted until the second year (T + 2:−1.9 (−2.8; −1.0) vs. T0:−2.7 (−3.2; −2.1) (p = 0.01) with a stabilization afterwards. A rapid GVz increase was noted at T + 1:1.0 (−0.8; 1.9) vs. T0:−1.5 (−2.0;−0.3). After the start of ETF until T + 3, a stabilization of FEV1% was noted. However, compared to controls, it remained significantly lower (p < 0.05).
ETF as a nutritional intervention has its effect on weight, height, GV, and BMI. To our knowledge this is the first study that describes the evolution of growth in ETFp. The effect on GV argues for a faster introduction of ETF in malnourished children with CF.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Turck D, Braegger CP, Colombo C, Declercq D, Morton A, Pancheva R, et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35:557–77.
Orenti A, Zolin A, Naehrlich L, van Rens J. ECFS Patient Registry annual data report. 2018:1–139.
Declercq D, Van Meerhaeghe S, Marchand S, Van Braeckel E, van Daele S, De Baets F, et al. The nutritional status in CF: Bein certain about the uncertainties. Clin Nutr. ESPEN. 2018;29:15–21.
Pencharz PB, Durie PR. Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr. 2000;19:387–94.
Erskine JM, Lingard C, Sontag M. Update on enteral nutrition support for cystic fibrosis. Nutr Clin Pract. 2007;22:223–32.
Vieni G, Faraci S, Collura M, Lombardo M, Traverso G, Cristadoro S, et al. Stunting is an independent predictor of mortality in patients with cystic fibrosis. Clin Nutr. 2013;32:382–5.
Oliver MR, Heine RG, Ng CH, Volders E, Olinsky A. Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis. Pediatr Pulmonol. 2004;37:324–9.
Steinkamp G, von der Hardt H. Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis. J Pediatr. 1994;124:244–9.
Bradley GM, Carson KA, Leonard AR, Mogayzel PJ Jr, Oliva-Hemker M. Nutritional outcomes following gastrostomy in children with cystic fibrosis. Pediatr Pulmonol. 2012;47:743–8.
Libeert D, Declercq D, Wanyama S, Thomas M, Van Daele S, De Baets F, et al. The effect of enteral tube feeding in cystic fibrosis: a registry based study. J Cyst Fibros. 2018;17:264–70.
White H, Morton AM, Conway SP, Peckham DG. Enteral tube feeding in adults with cystic fibrosis; patient choice and impact on long term outcomes. J Cyst Fibros. 2013;12:616–22.
Van Biervliet S, De Waele K, Van Winckel M, Robberecht E. Percutaneous endoscopic gastrostomy in cystic fibrosis: patient acceptance and effect of overnight tube feeding on nutritional status. Acta Gastro-enterol Belgica. 2004;67:241–4.
Schwarzenberg SJ, Hempstead SE, McDonald CM, Powers SW, Wooldridge J, Blair S, et al. Enteral tube feeding for individuals with cystic fibrosis: cystic Fibrosis Foundation evidence-informed guidelines. J Cyst Fibros. 2016;15:724–35.
Khalaf RT, Green D, Amankwah EK, Peck J, Carr V, Goldenberg NA, et al. Percutaneous endoscopic gastrostomy tubes may be associated with preservation of lung function in patients with cystic fibrosis. Nutr Clin Pract. 2019;34:290–6.
De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros. 2014;13:403–9.
Roelants M, Hauspie R, Hoppenbrouwers K. References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol. 2009;36:680–94.
Gunnell S, Christensen NK, McDonald C, Jackson D. Attitudes toward percutaneous endoscopic gastrostomy placement in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 2005;40:334–8.
Truby H, Cowlishaw P, O’Neil C, Wainwright C. The long term efficacy of gastrostomy feeding in children with cystic fibrosis on anthropometric markers of nutritonal status and pulmonary function. Open Respir Med J. 2009;3:112–5.
Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162:530–5 e1.
Bournez M, Bellis G, Huet F. Growth during puberty in cystic fibrosis: a retrospective evaluation of a French cohort. Arch Dis Child. 2012;97:714–20.
Woestenenk JW, Gulmans VA, van der Ent CK, Houwen RH. Height assessment in the Dutch-origin pediatric cystic fibrosis population. Nutr Clin Pract. 2017;32:130–2.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Declercq, D., Huysentruyt, K., Hauser, B. et al. Long-term use of tube feeding in children with cystic fibrosis: results from two Belgian CF centers. Eur J Clin Nutr 75, 620–627 (2021). https://doi.org/10.1038/s41430-020-00782-5